Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance01:23

Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance

The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Global current systems in the magnetosphere of Mercury.

Nature communications·2026
Same author

Response: Codeine in Breast Milk: Minimal Transfer, Still Risky for Neonates.

Paediatric anaesthesia·2026
Same author

Assessing peripheral oxytocin and cortisol levels and epigenetic variations of oxytocin receptor and glucocorticoid receptor genes in school-aged preterm-born children.

Progress in neurobiology·2026
Same author

Codeine and Metabolite Concentrations in the Breastfed Neonate.

Paediatric anaesthesia·2026
Same author

Cerebral Oximetry in Extremely Preterm Infants: 2-Year Follow-Up of the SafeBoosC-III Randomized Clinical Trial.

JAMA pediatrics·2026
Same author

Subclinical but significant: A multi-informant comparative study on early socio-emotional difficulties in preterm preschoolers.

Child and adolescent psychiatry and mental health·2026

Related Experiment Video

Updated: May 16, 2026

Comprehensive Evaluation of the Effectiveness and Safety of Placenta-Targeted Drug Delivery Using Three Complementary Methods
09:04

Comprehensive Evaluation of the Effectiveness and Safety of Placenta-Targeted Drug Delivery Using Three Complementary Methods

Published on: September 10, 2018

The paracetamol concentration-effect relation in neonates.

Karel Allegaert1, Gunnar Naulaers, Sophie Vanhaesebrouck

  • 1Neonatal Intensive Care Unit, University Hospitals Leuven, Leuven, Belgium. karel.allegaert@uz.kuleuven.ac.be

Paediatric Anaesthesia
|November 23, 2012
PubMed
Summary

Intravenous paracetamol effectively reduces pain in neonates. A loading dose of 20 mg/kg is associated with a significant decrease in pain scores, supporting its use for moderate pain management.

Related Experiment Videos

Last Updated: May 16, 2026

Comprehensive Evaluation of the Effectiveness and Safety of Placenta-Targeted Drug Delivery Using Three Complementary Methods
09:04

Comprehensive Evaluation of the Effectiveness and Safety of Placenta-Targeted Drug Delivery Using Three Complementary Methods

Published on: September 10, 2018

Area of Science:

  • Pharmacology
  • Neonatal Care
  • Pain Management

Background:

  • Intravenous (IV) paracetamol dosing in neonates lacks robust pharmacodynamic data.
  • Previous suggestions proposed a loading dose of 20 mg/kg followed by 10 mg/kg q6h to reach an effect compartment concentration of 11 mg/L.
  • Validation of this target concentration using neonatal pain scores is necessary.

Purpose of the Study:

  • To validate the proposed effect compartment concentration of IV paracetamol in neonates.
  • To assess the relationship between IV paracetamol administration and pain reduction using neonatal pain scores.

Main Methods:

  • Utilized pain scores (Leuven Neonatal Pain Score, LNPS) from neonates in the PARANEO study (NCT00969176) treated with IV paracetamol monotherapy.
  • Analyzed pain score trends using repeated measures ANOVA.
  • Fitted an Emax model with a delayed response compartment using population modeling to determine pharmacokinetic/pharmacodynamic parameters.

Main Results:

  • Nineteen neonates received IV paracetamol monotherapy for mild to moderate pain.
  • A significant trend (P=0.02) of reduced pain scores was observed within 30 minutes post-administration.
  • The Emax model indicated a maximum effect of 4.15 pain units, an EC50 of 2.07 mg/L, and an equilibration half-life (T1/2 keo) of 1.58 hours.

Conclusions:

  • Intravenous paracetamol demonstrates efficacy in managing moderate pain in neonates.
  • An effect compartment concentration of 10 mg/L, achieved with a 20 mg/kg loading dose, correlates with a 3.4 LNPS unit reduction.
  • The findings suggest comparable paracetamol effect compartment concentrations in neonates and children.